A detailed history of Baldrige Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Baldrige Asset Management LLC holds 364 shares of ABBV stock, worth $63,194. This represents 0.02% of its overall portfolio holdings.

Number of Shares
364
Previous 354 2.82%
Holding current value
$63,194
Previous $57,000 1.75%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 17, 2023

BUY
$144.61 - $166.54 $1,446 - $1,665
10 Added 2.82%
364 $58,000
Q4 2022

Jan 13, 2023

BUY
$138.31 - $165.87 $35,683 - $42,794
258 Added 268.75%
354 $57,000
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $10,100 - $11,252
96 New
96 $11,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $307B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Baldrige Asset Management LLC Portfolio

Follow Baldrige Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldrige Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldrige Asset Management LLC with notifications on news.